| UniProt ID | RL28_HUMAN | |
|---|---|---|
| UniProt AC | P46779 | |
| Protein Name | 60S ribosomal protein L28 | |
| Gene Name | RPL28 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 137 | |
| Subcellular Localization | ||
| Protein Description | Component of the large ribosomal subunit.. | |
| Protein Sequence | MSAHLQWMVVRNCSSFLIKRNKQTYSTEPNNLKARNSFRYNGLIHRKTVGVEPAADGKGVVVVIKRRSGQRKPATSYVRTTINKNARATLSSIRHMIRKNKYRPDLRMAAIRRASAILRSQKPVMVKRKRTRPTKSS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSAHLQWMV ------CCHHHHHHH | 25.13 | 12962325 | |
| 2 | Acetylation | ------MSAHLQWMV ------CCHHHHHHH | 25.13 | 12962325 | |
| 8 | Sulfoxidation | MSAHLQWMVVRNCSS CCHHHHHHHHCCCHH | 0.97 | 28183972 | |
| 11 | Methylation | HLQWMVVRNCSSFLI HHHHHHHCCCHHHHE | 27.33 | 115491993 | |
| 13 | S-palmitoylation | QWMVVRNCSSFLIKR HHHHHCCCHHHHECC | 2.24 | 29575903 | |
| 13 | S-nitrosylation | QWMVVRNCSSFLIKR HHHHHCCCHHHHECC | 2.24 | 2212679 | |
| 13 | Glutathionylation | QWMVVRNCSSFLIKR HHHHHCCCHHHHECC | 2.24 | 22555962 | |
| 14 | Phosphorylation | WMVVRNCSSFLIKRN HHHHCCCHHHHECCC | 27.89 | 28450419 | |
| 15 | Phosphorylation | MVVRNCSSFLIKRNK HHHCCCHHHHECCCC | 26.69 | 28450419 | |
| 19 | Acetylation | NCSSFLIKRNKQTYS CCHHHHECCCCCCCC | 52.65 | 25953088 | |
| 19 | Ubiquitination | NCSSFLIKRNKQTYS CCHHHHECCCCCCCC | 52.65 | 27667366 | |
| 19 | Ubiquitination | NCSSFLIKRNKQTYS CCHHHHECCCCCCCC | 52.65 | 21890473 | |
| 19 | Ubiquitination | NCSSFLIKRNKQTYS CCHHHHECCCCCCCC | 52.65 | 21890473 | |
| 22 | Ubiquitination | SFLIKRNKQTYSTEP HHHECCCCCCCCCCC | 48.31 | 21906983 | |
| 22 | Acetylation | SFLIKRNKQTYSTEP HHHECCCCCCCCCCC | 48.31 | 26051181 | |
| 22 | Ubiquitination | SFLIKRNKQTYSTEP HHHECCCCCCCCCCC | 48.31 | 21890473 | |
| 22 | 2-Hydroxyisobutyrylation | SFLIKRNKQTYSTEP HHHECCCCCCCCCCC | 48.31 | - | |
| 22 | Ubiquitination | SFLIKRNKQTYSTEP HHHECCCCCCCCCCC | 48.31 | 21890473 | |
| 24 | Phosphorylation | LIKRNKQTYSTEPNN HECCCCCCCCCCCCC | 22.50 | 28152594 | |
| 25 | Phosphorylation | IKRNKQTYSTEPNNL ECCCCCCCCCCCCCC | 15.88 | 28152594 | |
| 26 | Phosphorylation | KRNKQTYSTEPNNLK CCCCCCCCCCCCCCC | 29.67 | 28152594 | |
| 27 | Phosphorylation | RNKQTYSTEPNNLKA CCCCCCCCCCCCCCC | 45.08 | 28152594 | |
| 33 | 2-Hydroxyisobutyrylation | STEPNNLKARNSFRY CCCCCCCCCCCCEEE | 47.63 | - | |
| 33 | Ubiquitination | STEPNNLKARNSFRY CCCCCCCCCCCCEEE | 47.63 | 21890473 | |
| 33 | Ubiquitination | STEPNNLKARNSFRY CCCCCCCCCCCCEEE | 47.63 | 21890473 | |
| 33 | Acetylation | STEPNNLKARNSFRY CCCCCCCCCCCCEEE | 47.63 | 25953088 | |
| 33 | Methylation | STEPNNLKARNSFRY CCCCCCCCCCCCEEE | 47.63 | 21671109 | |
| 33 | Sumoylation | STEPNNLKARNSFRY CCCCCCCCCCCCEEE | 47.63 | - | |
| 33 | Sumoylation | STEPNNLKARNSFRY CCCCCCCCCCCCEEE | 47.63 | - | |
| 33 | Ubiquitination | STEPNNLKARNSFRY CCCCCCCCCCCCEEE | 47.63 | 23000965 | |
| 37 | Phosphorylation | NNLKARNSFRYNGLI CCCCCCCCEEECCEE | 12.92 | 28450419 | |
| 40 | Phosphorylation | KARNSFRYNGLIHRK CCCCCEEECCEEEEE | 16.15 | 30624053 | |
| 47 | Ubiquitination | YNGLIHRKTVGVEPA ECCEEEEEEEECEEC | 33.14 | 21890473 | |
| 47 | 2-Hydroxyisobutyrylation | YNGLIHRKTVGVEPA ECCEEEEEEEECEEC | 33.14 | - | |
| 47 | Ubiquitination | YNGLIHRKTVGVEPA ECCEEEEEEEECEEC | 33.14 | 21890473 | |
| 47 | Ubiquitination | YNGLIHRKTVGVEPA ECCEEEEEEEECEEC | 33.14 | 27667366 | |
| 47 | Acetylation | YNGLIHRKTVGVEPA ECCEEEEEEEECEEC | 33.14 | 26051181 | |
| 48 | Phosphorylation | NGLIHRKTVGVEPAA CCEEEEEEEECEECC | 23.58 | 29514088 | |
| 58 | 2-Hydroxyisobutyrylation | VEPAADGKGVVVVIK CEECCCCCEEEEEEE | 49.43 | - | |
| 58 | Ubiquitination | VEPAADGKGVVVVIK CEECCCCCEEEEEEE | 49.43 | 21890473 | |
| 58 | Sumoylation | VEPAADGKGVVVVIK CEECCCCCEEEEEEE | 49.43 | 28112733 | |
| 58 | Ubiquitination | VEPAADGKGVVVVIK CEECCCCCEEEEEEE | 49.43 | 21890473 | |
| 58 | Ubiquitination | VEPAADGKGVVVVIK CEECCCCCEEEEEEE | 49.43 | 21906983 | |
| 58 | Acetylation | VEPAADGKGVVVVIK CEECCCCCEEEEEEE | 49.43 | 26051181 | |
| 65 | Ubiquitination | KGVVVVIKRRSGQRK CEEEEEEECCCCCCC | 30.10 | 33845483 | |
| 65 | Sumoylation | KGVVVVIKRRSGQRK CEEEEEEECCCCCCC | 30.10 | 28112733 | |
| 65 | Ubiquitination | KGVVVVIKRRSGQRK CEEEEEEECCCCCCC | 30.10 | 21890473 | |
| 65 | 2-Hydroxyisobutyrylation | KGVVVVIKRRSGQRK CEEEEEEECCCCCCC | 30.10 | - | |
| 68 | Phosphorylation | VVVIKRRSGQRKPAT EEEEECCCCCCCCCE | 43.22 | 26278961 | |
| 72 | Ubiquitination | KRRSGQRKPATSYVR ECCCCCCCCCEEEEE | 30.99 | 27667366 | |
| 75 | Phosphorylation | SGQRKPATSYVRTTI CCCCCCCEEEEEHHC | 29.17 | 28152594 | |
| 76 | Phosphorylation | GQRKPATSYVRTTIN CCCCCCEEEEEHHCC | 24.60 | 28152594 | |
| 77 | Nitration | QRKPATSYVRTTINK CCCCCEEEEEHHCCC | 6.92 | - | |
| 77 | Phosphorylation | QRKPATSYVRTTINK CCCCCEEEEEHHCCC | 6.92 | 28152594 | |
| 80 | Phosphorylation | PATSYVRTTINKNAR CCEEEEEHHCCCCHH | 23.22 | - | |
| 84 | 2-Hydroxyisobutyrylation | YVRTTINKNARATLS EEEHHCCCCHHHHHH | 48.40 | - | |
| 84 | Acetylation | YVRTTINKNARATLS EEEHHCCCCHHHHHH | 48.40 | 26051181 | |
| 84 | Ubiquitination | YVRTTINKNARATLS EEEHHCCCCHHHHHH | 48.40 | 21906983 | |
| 89 | Phosphorylation | INKNARATLSSIRHM CCCCHHHHHHHHHHH | 22.94 | 30266825 | |
| 91 | Phosphorylation | KNARATLSSIRHMIR CCHHHHHHHHHHHHH | 21.26 | 30266825 | |
| 92 | Phosphorylation | NARATLSSIRHMIRK CHHHHHHHHHHHHHH | 27.10 | 30266825 | |
| 99 | Ubiquitination | SIRHMIRKNKYRPDL HHHHHHHHCCCCCHH | 47.03 | 23503661 | |
| 101 | Ubiquitination | RHMIRKNKYRPDLRM HHHHHHCCCCCHHHH | 45.75 | 21890473 | |
| 101 | Acetylation | RHMIRKNKYRPDLRM HHHHHHCCCCCHHHH | 45.75 | 19608861 | |
| 101 | Sumoylation | RHMIRKNKYRPDLRM HHHHHHCCCCCHHHH | 45.75 | - | |
| 101 | Sumoylation | RHMIRKNKYRPDLRM HHHHHHCCCCCHHHH | 45.75 | - | |
| 101 | Ubiquitination | RHMIRKNKYRPDLRM HHHHHHCCCCCHHHH | 45.75 | 19608861 | |
| 102 | Phosphorylation | HMIRKNKYRPDLRMA HHHHHCCCCCHHHHH | 36.45 | - | |
| 107 | Methylation | NKYRPDLRMAAIRRA CCCCCHHHHHHHHHH | 21.77 | 115492001 | |
| 115 | Phosphorylation | MAAIRRASAILRSQK HHHHHHHHHHHHCCC | 17.65 | 30266825 | |
| 120 | Phosphorylation | RASAILRSQKPVMVK HHHHHHHCCCCEEEE | 38.83 | 29083192 | |
| 122 | Ubiquitination | SAILRSQKPVMVKRK HHHHHCCCCEEEEEC | 40.60 | 27667366 | |
| 122 | Sumoylation | SAILRSQKPVMVKRK HHHHHCCCCEEEEEC | 40.60 | - | |
| 122 | Sumoylation | SAILRSQKPVMVKRK HHHHHCCCCEEEEEC | 40.60 | - | |
| 122 | Acetylation | SAILRSQKPVMVKRK HHHHHCCCCEEEEEC | 40.60 | 26051181 | |
| 122 | 2-Hydroxyisobutyrylation | SAILRSQKPVMVKRK HHHHHCCCCEEEEEC | 40.60 | - | |
| 125 | Sulfoxidation | LRSQKPVMVKRKRTR HHCCCCEEEEECCCC | 3.89 | 30846556 | |
| 127 | Ubiquitination | SQKPVMVKRKRTRPT CCCCEEEEECCCCCC | 33.82 | 22817900 | |
| 127 | 2-Hydroxyisobutyrylation | SQKPVMVKRKRTRPT CCCCEEEEECCCCCC | 33.82 | - | |
| 127 | Acetylation | SQKPVMVKRKRTRPT CCCCEEEEECCCCCC | 33.82 | 25953088 | |
| 129 | Ubiquitination | KPVMVKRKRTRPTKS CCEEEEECCCCCCCC | 53.02 | 23503661 | |
| 149 (in isoform 3) | Phosphorylation | - | 25599653 | ||
| 150 (in isoform 3) | Phosphorylation | - | 25599653 | ||
| 151 (in isoform 3) | Phosphorylation | - | 25599653 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RL28_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RL28_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RL28_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Characterization and analysis of posttranslational modifications ofthe human large cytoplasmic ribosomal subunit proteins by massspectrometry and Edman sequencing."; Odintsova T.I., Muller E.C., Ivanov A.V., Egorov T.A., Bienert R.,Vladimirov S.N., Kostka S., Otto A., Wittmann-Liebold B.,Karpova G.G.; J. Protein Chem. 22:249-258(2003). Cited for: MASS SPECTROMETRY, AND PROBABLE ACETYLATION AT SER-2. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-101, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115, AND MASSSPECTROMETRY. | |